• OPEN AN ACCOUNT
Indian Indices
Nifty
25,423.60 93.35
(0.37%)
Sensex
83,013.96 320.25
( 0.39%)
Bank Nifty
55,727.45 234.15
( 0.42%)
Nifty IT
36,750.25 303.10
( 0.83%)
Global Indices
Nasdaq
46,015.42 236.51
(0.52%)
Dow Jones
6,617.88 9.88
(-0.15%)
Hang Seng
45,342.39 552.01
(1.23%)
Nikkei 225
9,208.37 12.71
(0.14%)
Forex
USD-INR
88.02 0.00
(0.00%)
EUR-INR
104.02 0.00
(0.00%)
GBP-INR
120.02 0.00
(0.00%)
JPY-INR
0.60 0.00
(0.00%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
101.444166
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
78.05
388752.25
EPS(TTM)
Face Value()
Div & Yield %
20.76
1
0.99
 

As on: Sep 18, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,648.90 28.65 105605 78.05
Stock Price Details
Open Price() 1,626.00
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,650.95
Today's Low () 1,626.00
52-Week High () 1960.2
152-Week Low () 1555
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.99
Eps 20.76
Book Value 101.444166
Market Cap (.Cr) 388,752.25
Face Value 1
Market Lot 1
AGM Date Aug
Book Closure Date
ISIN No. INE044A01036


News
Sun Pharmaceutical Industries Ltd up for third consecutive session
Sun Pharma’s Gujarat facility gets official action indicated classification from US FDA
Sun Pharmaceutical Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
Sun Pharmaceutical Industries Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Investor Presentation
Sun Pharma drops as foreign broker downgrades on valuation, execution risks
Sun Pharmaceutical Industries Ltd gains for third consecutive session
Sun Pharmaceutical Industries Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates
More
Corporate Details
Incoporation Year   : 1993
Chairman : Dilip S Shanghvi
Bussiness Group : Sun Pharma
Registered Office
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-265-6615500
Fax:91-265-2354897
Fax:91-22-66317458
E-Mail : secretarial@sunpharma.com
URL : http://www.sunpharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE SENSEX
  • BSE 100
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE GREENEX
  • bse carbonex
  • NIFTY
  • CNX 500
  • CNX 100
  • CNX Pharma
  • CNX 200
  • NI15 Index
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi